EHA 2025: Real-World Insights on Belantamab Mafodotin in RRMM
/ Fredrik Schjesvold
EHA 2025: Overcoming Venetoclax Resistance
/ Justinas Daraskevicius
Personer med alvorlig psykisk sygdom og type 2-diabetes er dårligere behandlet for diabetes
/ Stine Hedegaard Scheuer / Marit Eika Jørgensen
Several Options for Frontline Treatment of MCL
/ Mats Jerkeman